Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2022
4-2022 Mise en place de l’immunothérapie orale pour l’allergie à l’arachide en pratique clinique aux États-Unis : huit conseils, S. Shahzad Mustafa, Rochester Regional Health and R Montagne, Aimmune Therapeutics
4-1-2022 Real World Adoption of FDA-approved Peanut Oral Immunotherapy with Palforzia, Sara Patrawala, University of Rochester School of Medicine and Dentistry, Rochester NY., Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.
4-2022 Standardisation de la poudre de graine d’Arachis hypogaea L. (arachide) allégée en graisses (PDAH) pour une immunothérapie orale : test des lots de matériel source, S A. Leonard, University of California San Diego; R Montagne, Aimmune Therapeutics; and S. Shahzad Mustafa, Rochester Regional Health
3-2022 Anaphylaxis knowledge gaps and future research priorities: A consensus report, Timothy E. Dribin, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., David Schnadower, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Julie Wang, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY., et al.
2-1-2022 Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of β-Lactam Cross-Reactivity, Allison Ramsey, Rochester Regional Health
2-1-2022 The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies, Kimberly Blumenthal, Allison Ramsey, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
1-18-2022 COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
1-6-2022 COVID, Emil P. Lesho, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health
Submissions from 2021
12-1-2021 Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose, Linh-An C. Tuong, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Mary Staicu, Rochester Regional Health, et al.
10-15-2021 Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia, S Shahzad Mustafa, Rochester Regional Health, Saad Jamshed, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, Missouri, United States of America., et al.
8-20-2021 CLL Society's Official Statement on Boosters for Cll (Chronic Lymphocytic Leukemia) Patients, Brian Koffman; Alan Z. Skarbnik; and S. Shahzad Mustafa, Rochester Regional Health
8-10-2021 Drug Allergy Management on the Move, Pascal Demoly, Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; IDESP UA11 INSERM-Univ Montpellier, Montpellier, France. and Allison Ramsey, Rochester Regional Health
6-22-2021 The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach, Matthew Greenhawt, Section of Allergy and Clinical Immunology, Food Challenge and Research Unit, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo., Elissa M. Abrams, Department of Pediatrics and Child Health, Section of Allergy and Immunology, The University of Manitoba, Winnipeg, Man, Canada., Marcus Shaker, Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon; Dartmouth Geisel School of Medicine, Hanover, NH., et al.
6-2021 Dupilumab Increases Aspirin Tolerance in Aspirin-Exacerbated Respiratory Disease, S Shahzad Mustafa, Rochester Regional Health and Karthik Vadamalai, Mercy Hospital, Springfield, Mo.
5-16-2021 Differences in Oral Food Challenge Reaction Severity Based on Increasing Age in a Pediatric Population, Katie Kennedy, Children's Hospital of Philadelphia, Philadelphia, PA, Maria Katerina C. Alfaro, Children's Hospital of Philadelphia, Philadelphia, PA, Zachary C. Spergel, University of Rochester, Rochester, NY, et al.
5-2021 Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic, S. Shahzad Mustafa, Rochester Regional Health; Karthik Vadamalai, Mercy Hospital, Springfield, Mo.; and Allison Ramsey, Rochester Regional Health
5-1-2021 Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelines, Susan Waserman, McMaster University, Heather Cruickshank, McMaster University, Kyla J. Hildebrand, The University of British Columbia, et al.
4-23-2021 Rheumatology Patient Satisfaction With Telemedicine During the COVID-19 Pandemic in the United States, Mahta Mortezavi, Rochester Regional Health, Sravani Lokineni, Rochester Regional Health, Megha Garg, Rochester Regional Health, et al.
4-6-2021 Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports [letter], S Shahzad Mustafa, Rochester Regional Health; Allison Ramsey, Rochester Regional Health; and Mary L. Staicu, Rochester Regional Health
4-5-2021 Adult Peanut Allergy, What We Know and What We Need to Learn, Soheila J. Maleki, United States Department of Agriculture, Agricultural Research Service; Suzanne S. Teuber, UC Davis School of Medicine; and S Shahzad Mustafa, Rochester Regional Health
4-1-2021 Examining the impact of a penicillin allergy skin testing brochure on inpatient perceptions: A pre-post intervention study, Mikaela Brown, St. John Fisher College, Joy Uzoma, St. John Fisher College, Ryan Vansice, St. John Fisher College, et al.
4-1-2021 Paediatric Allergy Practice in the Era of Coronavirus Disease 2019, S. Shahzad Mustafa, Rochester Regional Health, Marcus S. Shaker, Dartmouth-Hitchcock Medical Center, Daniel Munblit, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom, et al.
2-16-2021 Drug Allergy Labels Lost in Translation: From Patient to Charts and Backwards, Allison Ramsey, Rochester Regional Health, Eric Macy, Kaiser Permanente Southern California, San Diego, Calif., Anca-Mirela Chiriac, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France, et al.
2-1-2021 Microarray Analysis of Major Epitopes Among Tree Nut-Allergic Individuals May Explain Patterns of Cross-Desensitization, Stephen Gipson, USDA SRRC, Jacqueline Nesbit, USDA SRRC, Hsiaopo Cheng, USDA SRRC, et al.
2-2021 Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study, John T. Anderson, Clinical Research Center of Alabama, Vincent R. Bonagura, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Juthaporn Cowan, University of Ottawa, et al.